Albinism classification: Difference between revisions
Jump to navigation
Jump to search
(8 intermediate revisions by the same user not shown) | |||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
[[Albinism]] is classified based on genetic [[mutation]]. The different types of [[albinism]] include, [[Oculocutaneous albinism]]([[OCA]]), [[Hermansky-Pudlak syndrome]] ([[HPS]]),[[Chediak-Higashi syndrome]] ([[CHS]]), and [[Ocular albinism]] ([[OA]]). | |||
==Classification== | ==Classification== | ||
* [[Albinism]] is classified based on genetic [[mutation]] | * [[Albinism]] is classified based on genetic [[mutation]]<ref name="pmid19390472">{{cite journal| author=Summers CG| title=Albinism: classification, clinical characteristics, and recent findings. | journal=Optom Vis Sci | year= 2009 | volume= 86 | issue= 6 | pages= 659-62 | pmid=19390472 | doi=10.1097/OPX.0b013e3181a5254c | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19390472 }} </ref><ref>{{cite web |url=https://www.ncbi.nlm.nih.gov/books/NBK519018/ |title=Albinism - StatPearls - NCBI Bookshelf |format= |work= |accessdate=}}</ref> | ||
* The different types include: | * The different types and subtypes include: | ||
** [[Oculocutaneous albinism]]([[OCA]]) | ** [[Oculocutaneous albinism]]([[OCA]]); 4 subtypes | ||
** [[Hermansky-Pudlak syndrome]] ([[HPS]]) | ** [[Hermansky-Pudlak syndrome]] ([[HPS]]); 8 subtypes | ||
** [[Chediak-Higashi syndrome]] ([[CHS]]) | ** [[Chediak-Higashi syndrome]] ([[CHS]]); 1 type | ||
** [[Ocular albinism]] ([[OA]]) | ** [[Ocular albinism]] ([[OA]]); 2 types | ||
{| class="wikitable" | {| class="wikitable" | ||
|+ | |+ | ||
Albinism Types | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" + | Type | ! style="background:#4479BA; color: #FFFFFF;" align="center" + | Type | ||
! style="background:#4479BA; color: #FFFFFF;" align="center" + | Gene Position | ! style="background:#4479BA; color: #FFFFFF;" align="center" + | Gene Position | ||
Line 23: | Line 22: | ||
| style="background:#DCDCDC;" align="center" + | OCA1 | | style="background:#DCDCDC;" align="center" + | OCA1 | ||
| style="background:#F5F5F5;" +|11q14-21 | | style="background:#F5F5F5;" +|11q14-21 | ||
| style="background:#F5F5F5;" +| Tyrosinase | | style="background:#F5F5F5;" +| [[Tyrosinase]] | ||
|- | |- | ||
| style="background:#DCDCDC;" align="center" + |OCA2 | | style="background:#DCDCDC;" align="center" + |OCA2 | ||
| style="background:#F5F5F5;" +|15q11-13 | | style="background:#F5F5F5;" +|15q11-13 | ||
| style="background:#F5F5F5;" +|P protein | | style="background:#F5F5F5;" +|[[P-protein]] | ||
|- | |- | ||
| style="background:#DCDCDC;" align="center" + |OCA3 | | style="background:#DCDCDC;" align="center" + |OCA3 | ||
| style="background:#F5F5F5;" + |9p23 | | style="background:#F5F5F5;" + |9p23 | ||
| style="background:#F5F5F5;" + |Tyrosinase-related protein | | style="background:#F5F5F5;" + |[[Tyrosinase-related]] protein | ||
|- | |- | ||
| style="background:#DCDCDC;" align="center" + |OCA4 | | style="background:#DCDCDC;" align="center" + |OCA4 | ||
| style="background:#F5F5F5;" + |5p | | style="background:#F5F5F5;" + |5p | ||
| style="background:#F5F5F5;" + | SLC45A2 | | style="background:#F5F5F5;" + | [[SLC45A2]] | ||
|- | |||
| style="background:#DCDCDC;" align="center" + | HPS1 | |||
| style="background:#F5F5F5;" + |10q23.1-q23.3 | |||
| style="background:#F5F5F5;" + |[[HPS1]] | |||
|- | |||
| style="background:#DCDCDC;" align="center" + |HPS2 | |||
| style="background:#F5F5F5;" + |5q14.1 | |||
| style="background:#F5F5F5;" + |[[AP3B1]] | |||
|- | |||
| style="background:#DCDCDC;" align="center" + |HPS3 | |||
| style="background:#F5F5F5;" + |3q24 | |||
| style="background:#F5F5F5;" + |[[HPS3]] | |||
|- | |||
| style="background:#DCDCDC;" align="center" + |HPS4 | |||
| style="background:#F5F5F5;" + |22q11.2-q12.2 | |||
| style="background:#F5F5F5;" + |[[HPS4]] | |||
|- | |||
| style="background:#DCDCDC;" align="center" + |HPS5 | |||
| style="background:#F5F5F5;" + |11p15-p13 | |||
| style="background:#F5F5F5;" + |[[HPS5]] | |||
|- | |||
| style="background:#DCDCDC;" align="center" + |HPS6 | |||
| style="background:#F5F5F5;" + |10q24.3 | |||
| style="background:#F5F5F5;" + |[[HPS6]] | |||
|- | |||
| style="background:#DCDCDC;" align="center" + |HPS7 | |||
| style="background:#F5F5F5;" + |6p22.3 | |||
| style="background:#F5F5F5;" + |[[Dysbindin]] [[protein]] | |||
|- | |||
| style="background:#DCDCDC;" align="center" + |HPS8 | |||
| style="background:#F5F5F5;" + |19q13 | |||
| style="background:#F5F5F5;" + |[[BLOC1S3]] | |||
|- | |||
| style="background:#DCDCDC;" align="center" + |CHS | |||
| style="background:#F5F5F5;" + |1q42.1-q42.2 | |||
| style="background:#F5F5F5;" + |[[Lysosomal trafficking regulator]] | |||
|- | |||
| style="background:#DCDCDC;" align="center" + |OA ([[X-linked recessive]]) | |||
| style="background:#F5F5F5;" + |Xp22.3 | |||
| style="background:#F5F5F5;" + |[[GPR143]] | |||
|- | |||
| style="background:#DCDCDC;" align="center" + |AROA( [[autosomal recessive]]) | |||
| style="background:#F5F5F5;" + |Not a distinct position | |||
| style="background:#F5F5F5;" + |[[Tyrosinase]] in some cases;[[P protein]] in some cases | |||
|} | |} | ||
Latest revision as of 16:23, 21 August 2021
Albinism Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Albinism classification On the Web |
American Roentgen Ray Society Images of Albinism classification |
Risk calculators and risk factors for Albinism classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.[2]
Overview
Albinism is classified based on genetic mutation. The different types of albinism include, Oculocutaneous albinism(OCA), Hermansky-Pudlak syndrome (HPS),Chediak-Higashi syndrome (CHS), and Ocular albinism (OA).
Classification
- Albinism is classified based on genetic mutation[1][2]
- The different types and subtypes include:
- Oculocutaneous albinism(OCA); 4 subtypes
- Hermansky-Pudlak syndrome (HPS); 8 subtypes
- Chediak-Higashi syndrome (CHS); 1 type
- Ocular albinism (OA); 2 types
Type | Gene Position | Affected Protein |
---|---|---|
OCA1 | 11q14-21 | Tyrosinase |
OCA2 | 15q11-13 | P-protein |
OCA3 | 9p23 | Tyrosinase-related protein |
OCA4 | 5p | SLC45A2 |
HPS1 | 10q23.1-q23.3 | HPS1 |
HPS2 | 5q14.1 | AP3B1 |
HPS3 | 3q24 | HPS3 |
HPS4 | 22q11.2-q12.2 | HPS4 |
HPS5 | 11p15-p13 | HPS5 |
HPS6 | 10q24.3 | HPS6 |
HPS7 | 6p22.3 | Dysbindin protein |
HPS8 | 19q13 | BLOC1S3 |
CHS | 1q42.1-q42.2 | Lysosomal trafficking regulator |
OA (X-linked recessive) | Xp22.3 | GPR143 |
AROA( autosomal recessive) | Not a distinct position | Tyrosinase in some cases;P protein in some cases |
References
- ↑ Summers CG (2009). "Albinism: classification, clinical characteristics, and recent findings". Optom Vis Sci. 86 (6): 659–62. doi:10.1097/OPX.0b013e3181a5254c. PMID 19390472.
- ↑ "Albinism - StatPearls - NCBI Bookshelf".